Ignite Creation Date:
2024-05-06 @ 1:44 AM
Last Modification Date:
2024-10-26 @ 11:08 AM
Study NCT ID:
NCT01884623
Status:
COMPLETED
Last Update Posted:
2024-02-09
First Post:
2013-06-18
Brief Title:
Phase III Trial Comparing Methotrexate and Cetuximab in First-line Treatment of Recurrent andor Metastatic Squamous Cell Head and Neck Cancer
Sponsor:
Gustave Roussy Cancer Campus Grand Paris
Organization:
Gustave Roussy Cancer Campus Grand Paris
Organization Data
Organization:
Gustave Roussy Cancer Campus Grand Paris
Class:
OTHER
Study ID:
2012-004967-38
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Gustave Roussy Cancer Campus Grand Paris
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute France | OTHER_GOV |
| Ligue contre le cancer France | OTHER |
| Merck Serono International SA | INDUSTRY |